Short Interest in EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Grows By 4,525.3%

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a large increase in short interest in June. As of June 15th, there was short interest totaling 192,041 shares, an increase of 4,525.3% from the May 31st total of 4,152 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 331,947 shares, the days-to-cover ratio is currently 0.6 days.

Analysts Set New Price Targets

ESLOY has been the subject of several research reports. Zacks Research lowered EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a research report on Tuesday, May 12th. They set a “hold” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

EssilorLuxottica Price Performance

Shares of EssilorLuxottica stock traded down $0.97 during trading on Thursday, hitting $94.47. The company’s stock had a trading volume of 197,797 shares, compared to its average volume of 123,083. EssilorLuxottica has a 52 week low of $93.42 and a 52 week high of $186.81. The company has a fifty day simple moving average of $104.93 and a two-hundred day simple moving average of $129.49. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.